Samir Kaul, Director at Guardant Health, Inc. (GH), sold 50,000 shares at $81.49 ($2.1M) on 2020-03-04, disclosed to the SEC on 2020-03-06.
Open-market sale of $2.1M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 25,000 | $0 | 0.0% |
| 2 | $81.49 | 4,900 | $399K | 19.4% |
| 3 | $82.53 | 16,800 | $1.4M | 67.3% |
| 4 | $82.95 | 3,300 | $274K | 13.3% |
| Total | $41.19 avg | 50,000 | $2.1M | 100% |
| Filing → |
| GH | SELL | 2020-10-20 | $2.0M | — | Filing → |
| GH | SELL | 2020-09-21 | $1.8M | — | Filing → |
| GH | SELL | 2020-08-19 | $1.7M | — | Filing → |